Oloyede and colleagues advocate for updating haematological monitoring requirements for clozapine, arguing that current protocols overestimate the risk of clozapine-induced agranulocytosis. Their research suggests that stringent monitoring may unnecessarily limit access to clozapine, a crucial treatment for resistant schizophrenia. The editorial supports calls for international consensus to carefully weigh the pros and cons of relaxing monitoring guidelines while ensuring comprehensive care for patients.

中文翻译：

---

氯氮平监测要求：是时候更新了吗？

Oloyede 及其同事主张更新氯氮平的血液学监测要求，认为目前的方案高估了氯氮平诱导的粒细胞缺乏症的风险。他们的研究表明，严格的监测可能会不必要地限制氯氮平的获得，氯氮平是治疗耐药性精神分裂症的关键方法。社论支持呼吁国际共识，在确保对患者进行全面护理的同时，仔细权衡放宽监测指南的利弊。